NHS cancer treatment waiting times increasing, figures show

June 08, 2023 09:52 AM AEST | By PAMEDIA
Follow us on Google News:

Cancer waiting times across the NHS in England have got worse, according to new data.

Figures from NHS England show 61.0% of cancer patients who had their first treatment in April after an urgent GP referral had waited less than two months for treatment to start.

This is down from 63.5% in March. The target is 85%.

Meanwhile, the proportion of cancer patients who saw a specialist within two weeks of being referred urgently by their GP fell from 83.9% in March to 77.7% in April, remaining below the 93% target and the lowest div since September 2022.

The 93% target was last hit in May 2020, during the early months of the Covid-19 pandemic.

Elsewhere, 71.3% of patients urgently referred for suspected cancer were diagnosed or had cancer ruled out within 28 days, down from 74.2% the previous month.

The NHS elective recovery plan sets a goal of March 2024 for 75% of patients who have been urgently referred by their GP for suspected cancer to be diagnosed or have cancer ruled out within 28 days.

Overall, some 218,060 urgent cancer referrals were made by GPs in England in April, down month-on-month (by 16% compared with March 2023) but up year-on-year (by 2% compared with April 2022).

Seven per cent more people were referred for urgent cancer checks in the year to April, though the data shows they are having to wait longer to be seen or treated.

It comes after radiology leaders warned cancer patients face worsening NHS delays and the prospect of more gruelling treatment due to too few staff.

A poll of all 60 directors of the UK’s cancer centres by the Royal College of Radiologists (RCR) found 95% feel staff shortages are leading to longer waiting times for appointments and delays in cancer treatment.

Half of services surveyed reported “frequent delays” in patients starting radiotherapy, occurring every month or most months, while in one in five (22%) centres, this is happening most weeks or every week.

The RCR warned staff shortages mean people are waiting longer than necessary to start chemotherapy or radiotherapy, while some doctors are now having to make “difficult decisions” about who to prioritise and are having to send patients to different hospitals.

The latest NHS divs also show 371,111 people in England had been waiting more than 52 weeks to start routine hospital treatment at the end of April. This is up from 359,798 at the end of March.

Meanwhile, 11,477 people are estimated to have been waiting more than 18 months to start routine hospital treatment at the end of April – this is up from 10,737 at the end of March.

Overall, the number of people in England waiting to start routine hospital treatment – for issues such as knee and hip replacements – has also risen to a record high.

An estimated 7.4 million people were waiting to start treatment at the end of April, up from 7.3 million in March.

NHS England said staff are continuing to make progress on recovering routine services despite the it facing “the most disruptive industrial action in its history in April”, with four days of strikes by junior doctors resulting in more than 195,000 appointments and procedures having to be rescheduled.

Accident and emergency units across the country also experienced the busiest May on record, it said.

NHS national medical director Professor Sir Stephen Powis said: “Despite the NHS continuing to see high levels of demand across urgent and emergency care, hard-working staff are continuing to deliver improvements as set out in our urgent and emergency recovery plan.

“Even as hospitals dealt with the most disruptive industrial action in its history, average waits for people on the waiting list dropped to just under 14 weeks – the lowest it’s been since before winter.

“We knew the overall waiting list would continue to increase for a time as people who may have put off coming forward for care over the past few years of the pandemic sought help, and that demand would be reflected in other areas as well – today’s data shows another record 12 months for cancer treatment and referrals, with more than ever before getting checked and starting treatment.

“We continue to urge people to come forward because the earlier cancer is detected, the easier it is to treat.”


The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

Top ASX Listed Companies

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK